Innovating on Inhaled Bioequivalence: A Critical Analysis of the Current Limitations, Potential Solutions and Stakeholders of the Process

• Główni autorzy: Jonattan Gallegos-Catalán (Autor), Zachary Warnken (Autor), Tania F. Bahamondez-Canas (Autor), Daniel Moraga-Espinoza (Autor)
• Format: Książka
• Wydane: MDPI AG, 2021-07-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Orally inhaled drug products (OIDPs) are an important group of medicines traditionally used to treat pulmonary diseases. Over the past decade, this trend has broadened, increasing their use in other conditions such as diabetes, expanding the interest in this administration route. Thus, the bioequiva...